Increased serum levels of CD95 in Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 13, Issue 3, 2002, Pages 178-182

  Richartz, Elke ^a   Noda, S ^a   Schott, K ^a   Gunthner A ^a   Lewczuk, P ^b   Bartels, M ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Alzheimer's disease; Apo 1; Apoptosis; CD95; Fas; Neurodegenerative disorders; Peripheral markers

Indexed keywords

FAS ANTIGEN;

AGED; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BLOOD LEVEL; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; LYMPHOCYTE; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIGENS, CD95; APOPTOSIS; BIOLOGICAL MARKERS; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED;

EID: 0036121084     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048650     Document Type: Article

References (44)

1. Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis
2. Immunohistological evidence for apoptosis in Alzheimer's disease
3. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ
4. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes
5. Evidence for apoptotic cell death in Alzheimer's disease
6. Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease
7. Cell death mechanism in Parkinson's disease
8. Correlates of p53 and Fas (CD 95)-mediated apoptosis in Alzheimer's disease
9. Direct evidence of oxidative injury produced by the Alzheimer's β-amyloid peptide (1-40) in cultured hippocampal neurons
10. The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice
11. Presenilins, the endoplasmic reticulum, and neuronal apoptosis in AD
12. Neuronal apoptosis induced by β-amyloid is mediated by caspase-8
13. The Fas death factor
14. Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients
15. Intrathecal expression of proteins regulating apoptosis in acute stroke
16. The soluble form of fas-molecule is elevated in parkinsonian brain tissues
17. Indices of oxidative stress in Parkinson's disease, Alzheimer's disease and dementia with Lewy bodies
18. Fas antigen expression in brains of patients with Alzheimer-type dementia
19. p53- and CD95-associated apoptosis in neurodegenerative disorders
20. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule
21. The apoptosis-1/Fas protein in human systemic lupus erythematosus
22. Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias
23. Serum levels of soluble Fas/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases
24. Accumulation of soluble Fas in inflamed joints of patients with rheumatoid arthritis
25. Increased serum levels of sFas in patients with Graves disease
26. Fas and FasL in the homeostatic regulation of immune responses
27. Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover
28. CD95-CD95L: Can the brain learn from the immune system?
29. Serum levels of Fas/Apo1 and bcl-2 in children with HIV-1 infection
30. Plasma sFas and sFas ligand levels in patients with thrombocytopenic purpura and in those with disseminated intravascular coagulation
31. The role of fas and related death receptors in autoimmune and other disease states
32. Increased sFas in patients with dilatative cardiomyopathy
33. Lymphocytes as cell model to study apoptosis in Alzheimer's disease: Vulnerability to programmed cell death appears to be altered
34. Partial characterization of apoptotic factor in Alzheimer plasma
35. Circulating cytokines in Alzheimer's disease
36. The calcium response of human T lymphocytes is decreased in aging but increased in Alzheimer's dementia
37. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
38. 'Mini-Mental-State': A practical method for grading the cognitive state of patients for the clinician
39. Alterations of cytokine levels in Alzheimer's disease
40. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's disease individuals
41. Fas-induced death of a murine pulmonary epithelia cell line: Modulation by proinflammatory cytokines
42. Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia
43. Cell death or synaptic loss in Alzheimer disease
44. Blood levels of alpha-1-antichymotrypsin and risk factors for Alzheimer's disease. Effects of gender and apolipoprotein E genotype